ChiCTR2500103592 版本V1.0 版本创建时间2025/05/30 17:57:40 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500103592 

最近更新日期:

Date of Last Refreshed on:

2025-05-30 17:57:35 

注册时间:

Date of Registration:

2025-05-30 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

儿童阻塞性睡眠呼吸暂停人工智能辅助诊断系统的构建

Public title:

Construction of artificial intelligence-assisted diagnosis system for obstructive sleep apnea in children

注册题目简写:

English Acronym:

研究课题的正式科学名称:

儿童阻塞性睡眠呼吸暂停人工智能辅助诊断系统的构建

Scientific title:

Construction of artificial intelligence-assisted diagnosis system for obstructive sleep apnea in children

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

徐宏鸣 

研究负责人:

徐宏鸣 

Applicant:

Xu Hongming 

Study leader:

Xu Hongming 

申请注册联系人电话:

Applicant telephone:

+86 139 1708 6351

研究负责人电话:

Study leader's
telephone:

+86 139 1708 6351

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

xuhongming@188.com

研究负责人电子邮件:

Study leader's E-mail:

xuhongming@188.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市普陀区泸定路355号

研究负责人通讯地址:

上海市普陀区泸定路355号

Applicant address:

No. 355, Luding Road, Putuo District, Shanghaia

Study leader's address:

No. 355, Luding Road, Putuo District, Shanghai

申请注册联系人邮政编码:

Applicant postcode:

200062

研究负责人邮政编码:

Study leader's postcode:

200062

申请人所在单位:

上海市儿童医院

Applicant's institution:

Shanghai Children's Hospital

研究负责人所在单位:

上海市儿童医院

Affiliation of the Leader:

Shanghai Children's Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025R011-E01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

上海市儿童医院伦理委员会

Name of the ethic committee:

Ethics Committee of Shanghai Children's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-01-09 00:00:00

伦理委员会联系人:

何蕾

Contact Name of the ethic committee:

He Lei

伦理委员会联系地址:

上海市普陀区泸定路355号

Contact Address of the ethic committee:

No. 355, Luding Road, Putuo District, Shanghai

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 21 5297 6581

伦理委员会联系人邮箱:

Contact email of the ethic committee:

hl@shchildren.com.cn

研究实施负责(组长)单位:

上海市儿童医院

Primary sponsor:

Shanghai Children's Hospital

研究实施负责(组长)单位地址:

上海市普陀区泸定路355号

Primary sponsor's address:

No. 355, Luding Road, Putuo District, Shanghai

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海

市(区县):

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市儿童医院

具体地址:

普陀区泸定路355号

Institution
hospital:

Shanghai Children's Hospital

Address:

No. 355, Luding Road, Putuo District, Shanghai

经费或物资来源:

上海市卫生健康委员会

Source(s) of funding:

Shanghai Municipal Health Commission

研究疾病:

儿童阻塞性睡眠呼吸暂停  

Target disease:

Obstructive sleep apnea in children

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

本研究旨在利用人工智能技术,结合大样本量的临床资料、辅助检查结果及鼾声声学特征等多维度数据,通过机器学习探索一种能够综合现有主客观指标的智能诊断体系,以辅助临床医生评估患儿手术指征。此体系将提升儿童睡眠呼吸暂停诊断的准确性和治疗的科学性,并有助于大规模患儿评估筛查。  

Objectives of Study:

This study aims to use artificial intelligence technology, combined with a large sample of clinical data, auxiliary examination results, snoring acoustic characteristics and other multidimensional data, and explore an intelligent diagnosis system that can integrate existing subjective and objective indicators through machine learning to assist clinicians in evaluating surgical indications of children. This system will improve the accuracy of diagnosis and scientific treatment of sleep apnea in children, and help to evaluate and screen large-scale children.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.0-18 岁患儿; 2.临床症状提示有腺样体和(或)扁桃体肥大; 3.无接受腺样体和(或)扁桃体肥大手术治疗的禁忌症; 4.无接受软性电子鼻咽喉镜检查的禁忌症。

Inclusion criteria

1.Children aged 1.0 to 18 years; 2. Clinical symptoms suggest adenoid and/or tonsillar hypertrophy; 3. No contraindications to surgical treatment of adenoid and/or tonsillar hypertrophy; 4. No contraindications to soft electronic rhinolaryngoscopy.

排除标准:

1.有腺样体和(或)扁桃体切除手术史患儿; 2.需要直接进行手术治疗,无需随访治疗的患儿; 3.存在接受腺样体和(或)扁桃体肥大手术的禁忌症; 4.存在接受软性电子鼻咽喉镜检查的禁忌症; 5.合并其他系统疾病; 6.存在颌面部结构异常; 7.无法获得知情同意者。

Exclusion criteria:

1. Children with a history of adenoids and/or tonsillectomy; 2. Children who need direct surgical treatment without follow-up treatment; 3. Presence of contraindications to undergoing surgery for adenoid and (or) tonsillar hypertrophy; 4. Presence of contraindications to undergoing soft electronic rhinolaryngoscopy; 5. Combined with other systemic diseases; 6. Presence of abnormal maxillofacial structure; 7. Those who are unable to obtain informed consent.

研究实施时间:

Study execute time:

From 2025-01-01 00:00:00 To 2027-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-06-01 00:00:00 To 2027-12-31 00:00:00

干预措施:

Interventions:

组别:

睡眠打鼾(伴或不伴有睡眠张口呼吸)观察组

样本量:

2000

Group:

Sleep snoring (with or without sleep mouth breathing) observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

 

Country:

China

Province:

Shanghai

City:

单位(医院):

上海市儿童医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Children's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

鼻咽喉镜图像(腺样体、扁桃体分级评分)

指标类型:

主要指标

Outcome:

Nasopharyngoscopy image (Adenoid and tonsil grading)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

临床数据

指标类型:

主要指标

Outcome:

Clinical data

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

鼾声

指标类型:

主要指标

Outcome:

Snoring sound

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 0 years
最大 Max age 18 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-05-30 17:57:35